Imunon, Inc. (IMNN) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Imunon, Inc. faces a significant risk from market activities such as short selling, which can lead to a decline in the market price of its Common Stock. These activities could create negative momentum, encouraging further short sales and potentially resulting in both temporary and long-term price drops. The company is unable to predict the impact of future stock issuances or sales on its market price, or how these might influence short selling activities. Consequently, large sales or the perception of potential sales could materially and adversely affect the stock’s market value.
The average IMNN stock price target is $12.00, implying 184.36% upside potential.
To learn more about Imunon, Inc.’s risk factors, click here.